Has Adam Goldstein, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,184 in general payments to Adam Goldstein, MD across 24 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Adam Goldstein, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Adam Goldstein, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Adam Goldstein, MD

Nephrology · New Britain, CTNPI 1083685382

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $959 of the $1,184 with a category attached, or 81.0%. It is spread thinly across 12 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations.

$1,184in general payments, 2019–2025

Across 24 payments — averaging $49.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Baxter Healthcare$256
Novo Nordisk$246
Vifor Pharma, Inc.$200
Amgen$150
Calliditas Therapeutics US Inc.$125
Intuitive Surgical$95
plus $113 from 6 others

What the payments were for

Speaking & faculty fees$20017%
Food & beverage$95981%
Education$252%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Baxter Healthcare	2	$256
Novo Nordisk	2	$246
Vifor Pharma, Inc.	1	$200
Amgen	7	$150
Calliditas Therapeutics US Inc.	1	$125
Intuitive Surgical	1	$95
Fresenius USA Marketing, Inc.	2	$30
Akebia Therapeutics Inc	1	$21
Otsuka America Pharmaceutical, Inc.	1	$19
Preventice Services, LLC	1	$17
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$17
Travere Therapeutics, Inc.	4	$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,184 in reported general payments places this provider in the 60th percentile of 144 nephrology providers in Connecticut.

See all nephrology providers in Connecticut →

Medicare billing

Part B allowed, 2024

$183,588

Medicare patients

239

Services billed

1,208

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
XphozahTenapanor Hcl	29	$102,201
FarxigaDapagliflozin Propanediol	34	$37,027
Sevelamer Carbonate	108	$28,986
LokelmaSodium Zirconium Cyclosilicate	20	$18,703
Calcitriol	265	$2,516
Potassium Chloride	24	$2,056
Torsemide	53	$1,354
Midodrine Hcl	17	$1,288
Potassium Citrate ErPotassium Citrate	29	$1,105
Valsartan	53	$965
Carvedilol	100	$825
Furosemide	172	$655
Hydralazine Hcl	62	$654
Amlodipine Besylate	101	$606
Allopurinol	29	$518

Paid to pharmacies, not to this prescriber.

Other nephrology in New Britain

Sanjay FernandoNew Britain$3K
Susan HalleyNew Britain$1K
Zeynep EbciogluNew Britain$1K
Robert AlpernNew Haven$4.9M
Ari GellerBloomfield$209K
Richard FormicaNew Haven$198K
Stefan SomloNew Haven$111K
James GavinTrumbull$103K
Fredric FinkelsteinNew Haven$70K
Justin BelcherNew Haven$59K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →